Skip to main content

Table 1 Evaluation of anti-tumor effects of plant-derived foods/nutraceuticals in rat mammary carcinoma model

From: Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention

  Tumor frequency Tumor incidence (%) Tumor latency (days) References
Chlorella pyrenoidosa
 CONT 2.88 79.20 70.74 [13]
 CHLO 0.3 2.00 80.00 74.90
 CHLO 3 1.12a 68.00 83.18a
Hordeum vulgare, L. phylloma
 CONT 3.12 80.00 87.50 [14]
 BAR 0.3 1.96 72.00 88.28
 BAR 3 2.72 80.00 77.70
Flavin7®
 CONT 3.40 100.00 66.64 [15]
 FLA 0.3 2.44 92.00 70.91
 FLA 3 1.44b 76.00c 74.42
Origanum vulgare L., haulm
 CONT 2.96 72.00 65.33 [16]
 ORE 0.3 1.32a 40.00d 75.60
 ORE 3 2.36 72.00 77.78d
Syzygium aromaticum L., glove buds
 CONT 4.20 84.00 69.33 [17]
 CLO 0.1 2.20c 80.00 75.25
 CLO 1 1.75e 87.50 76.67
  1. Footnote: CONT control group, CHLO chlorella group, BAR young barley group, FLA flavin group (fruit peel polyphenol extract), ORE oregano group, and CLO clove buds group. Foods/nutraceuticals were administered dietary in a concentrations of 0.3 and 3 % (3, resp. 30 g/kg of the diet), with exception of cloves with dosing of 0.1 and 1 %
  2. Significantly different, ap < 0.02, bp <0 .001, cp < 0.05, dp < 0.03, ep < 0.01 vs CONT